Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes

Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize pro-inflammatory and pro-resolving (i.e., mediators involved in the resolution of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Prostaglandins Other Lipid Mediat
Main Authors: Shivakoti, Rupak, Dalli, Jesmond, Kadam, Dileep, Gaikwad, Sanjay, Barthwal, Madhusudan, Colas, Romain A., Mazzacuva, Francesca, Lokhande, Rahul, Dharmshale, Sujata, Bharadwaj, Renu, Kagal, Anju, Pradhan, Neeta, Deshmukh, Sona, Atre, Sachin, Sahasrabudhe, Tushar, Kakrani, Arjun, Kulkarni, Vandana, Raskar, Swapnil, Suryavanshi, Nishi, Chon, Sandy, Gupte, Akshay, Gupta, Amita, Gupte, Nikhil, Arriaga, María B., Fukutani, Kiyoshi F., Andrade, Bruno B., Golub, Jonathan E., Mave, Vidya
פורמט: Artigo
שפה:Inglês
יצא לאור: 2019
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067657/
https://ncbi.nlm.nih.gov/pubmed/31726221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2019.106398
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים